128 filings
Page 2 of 7
8-K
kp2qc
22 Jan 24
Entry into a Material Definitive Agreement
6:12am
8-K
m25oafyjsfe33rxnx
11 Jan 24
Entry into a Material Definitive Agreement
7:50pm
8-K
b4g41kjm3djmzjjna
8 Jan 24
Entry into a Material Definitive Agreement
5:19pm
8-K
urh1rigr78y jmt4u2sx
28 Dec 23
Other Events
4:14pm
8-K
deq1ct03 gyc
27 Dec 23
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
4:02pm
8-K
rv8v364ydeo4s0r
27 Dec 23
Entry into a Material Definitive Agreement
4:01pm
8-K
8t3y3kt1ljj3
14 Nov 23
NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
4:36pm
8-K
hk4ndsm5y gdgq1
30 Oct 23
Regulation FD Disclosure
8:05am
8-K
krashy95th jvv
24 Oct 23
Other Events
8:05am
8-K/A
5zx3lxyzmdtgki7apujn
19 Oct 23
Financial Statements and Exhibits
5:23pm
8-K
o9uq4ahrhbyg6tuto
5 Oct 23
Index to Financial Statements
5:12pm
8-K
3kb7hw0n2h 81jiq
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
25
kfe0zelp
29 Sep 23
Voluntary exchange delisting
4:29pm
CERT
f6q 5dvu59az5pf5x
29 Sep 23
Certification of approval for exchange listing
4:16pm
8-K
rwbcd0
29 Sep 23
Submission of Matters to a Vote of Security Holders
3:11pm
8-A12B
ukzosb7r53e35 hmuyok
29 Sep 23
Registration of securities on exchange
12:03pm